NYSE:BSX
Boston Scientific Corporation Stock News
$73.17
-0.0900 (-0.123%)
At Close: Apr 26, 2024
3 Medical Products Stocks Set to Beat This Earnings Season
12:31pm, Friday, 26'th Apr 2024
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
Here's Why Boston Scientific (BSX) is a Strong Momentum Stock
10:55am, Friday, 26'th Apr 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
01:41pm, Wednesday, 24'th Apr 2024
Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.
AHCO vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 24'th Apr 2024
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Boston Scientific (BSX). But which of these two stocks presents investors with the bet
Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart Device Sales
11:40am, Wednesday, 24'th Apr 2024
Shares of Boston Scientific (BSX) hit an all-time high Wednesday as the maker of medical equipment reported better-than-anticipated quarterly results and boosted its guidance on demand for its cardiov
Boston Scientific (BSX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:00am, Wednesday, 24'th Apr 2024
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wal
Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates
08:41am, Wednesday, 24'th Apr 2024
Boston Scientific (BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago.
Boston Scientific Stock Rises on More Than Just an Earnings Beat
08:30am, Wednesday, 24'th Apr 2024
The medical-device company tops first-quarter sales and profit estimates.
Boston Scientific raises annual profit forecast on strong demand for heart devices
06:40am, Wednesday, 24'th Apr 2024
Medical device maker Boston Scientific raised its annual profit forecast on Wednesday as the company banks on resilient demand for its heart devices, with post-pandemic elective surgical procedures pi
Boston Scientific's stock jumps 2.7% after earnings top estimates
06:38am, Wednesday, 24'th Apr 2024
Boston Scientific Corp.'s stock BSX, +1.43% rose 2.7% early Wednesday, after the medical tech company's first-quarter earnings beat analyst estimates. The company had net income of $495 million, or 33
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
12:41pm, Tuesday, 23'rd Apr 2024
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics
10:20am, Friday, 19'th Apr 2024
Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for th
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
11:46am, Tuesday, 16'th Apr 2024
Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.
Boston Scientific (BSX) Faces Rising Costs, Competition
10:31am, Wednesday, 10'th Apr 2024
With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.
AHCO or BSX: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 08'th Apr 2024
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Boston Scientific (BSX). But which of these two stocks presents investors with the bet